Literature DB >> 16423039

Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.

Jason D Marshall1, Darren S Heeke, Christi Abbate, Priscilla Yee, Gary Van Nest.   

Abstract

Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-gamma (IFN-gamma) and to exert lytic activity. Since NK cells lack the ISS receptor TLR9, the exact pathway by which NK cells are activated by ISS is unclear. We determined that ISS-induced IFN-gamma from NK cells is primarily dependent upon IFN-alpha release from plasmacytoid dendritic cells (PDCs), which directly activates the NK cell. However, further analysis indicated that other PDC-released soluble factor(s) may contribute to IFN-gamma induction. Indeed, tumour necrosis factor-alpha (TNF-alpha) was identified as a significant contributor to ISS-mediated activation of NK cells and was observed to act in an additive fashion with IFN-alpha in the induction of IFN-gamma from NK cells and to up-regulate CD69 expression on NK cells. This activity of TNF-alpha, however, was dependent upon the presence of PDC-derived factors such as type I interferon. These results illustrate an important function for type I interferon in innate immunity, which is not only to activate effectors like NK cells directly, but also to prime them for enhanced activation by other factors such as TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423039      PMCID: PMC1782206          DOI: 10.1111/j.1365-2567.2005.02261.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

1.  Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.

Authors:  Gunther Hartmann; Julia Battiany; Hendrik Poeck; Moritz Wagner; Miren Kerkmann; Norbert Lubenow; Simon Rothenfusser; Stefan Endres
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

2.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

Authors:  Gaetan Jego; A Karolina Palucka; Jean-Philippe Blanck; Cecile Chalouni; Virginia Pascual; Jacques Banchereau
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 3.  Immunotherapeutic uses of CpG oligodeoxynucleotides.

Authors:  Dennis M Klinman
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

4.  Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides.

Authors:  Jonathan Baines; Esteban Celis
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

5.  Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.

Authors:  Jason D Marshall; Karen Fearon; Christi Abbate; Sandhya Subramanian; Priscilla Yee; Josh Gregorio; Robert L Coffman; Gary Van Nest
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

6.  IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences.

Authors:  Omar Duramad; Karen L Fearon; Jean H Chan; Holger Kanzler; Jason D Marshall; Robert L Coffman; Franck J Barrat
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

7.  A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

Authors:  Scott A Halperin; Gary Van Nest; Bruce Smith; Simin Abtahi; Heather Whiley; Joseph J Eiden
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

8.  Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.

Authors:  Troy J Kemp; Bennett D Elzey; Thomas S Griffith
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.

Authors:  Simona Sivori; Michela Falco; Mariella Della Chiesa; Simona Carlomagno; Massimo Vitale; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-24       Impact factor: 11.205

10.  Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice.

Authors:  Javeed A Shah; Patricia A Darrah; David R Ambrozak; Tara N Turon; Susana Mendez; Joanna Kirman; Chang-You Wu; Nicolas Glaichenhaus; Robert A Seder
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  32 in total

1.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles.

Authors:  Daniel R Tonkin; Alan Whitmore; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

4.  HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.

Authors:  Elena Martinelli; Claudia Cicala; Donald Van Ryk; Diana J Goode; Katilyn Macleod; James Arthos; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

5.  Antigen-presenting phagocytic cells ingest malaria parasites and increase HIV replication in a tumor necrosis factor α-dependent manner.

Authors:  Marika Orlov; Florin Vaida; Kathryn Williamson; Qianqian Deng; David M Smith; Patrick E Duffy; Robert T Schooley
Journal:  J Infect Dis       Date:  2014-06-05       Impact factor: 5.226

6.  Early expression of local cytokines during systemic Candida albicans infection in a murine intravenous challenge model.

Authors:  Voon Kin Chin; Kuan Jeang Foong; Abdullah Maha; Basir Rusliza; Mohtarrudin Norhafizah; Pei Pei Chong
Journal:  Biomed Rep       Date:  2014-09-15

7.  Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

Authors:  Daniel R Tonkin; Patricia Jorquera; Tracie Todd; Clayton W Beard; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

8.  Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.

Authors:  R Keith Reeves; Qing Wei; Jackie Stallworth; Patricia N Fultz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

9.  Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer.

Authors:  Chi-Mu Chuang; Archana Monie; Annie Wu; Chih-Ping Mao; Chien-Fu Hung
Journal:  Hum Gene Ther       Date:  2009-04       Impact factor: 5.695

10.  Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.

Authors:  Dhammika H M L P Navarathna; Kenneth W Nickerson; Gerald E Duhamel; Thomas R Jerrels; Thomas M Petro
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.